NicOx SA: Santen Grants Eupharmed Extension Of Exclusive Rights To Distribute Cationorm® In Italy

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SOPHIA ANTIPOLIS, France, May 28, 2014 (GLOBE NEWSWIRE) -- Nicox S.A. (NYSE Euronext Paris: COX), the international ophthalmic company, today announces that its wholly-owned Italian subsidiary Eupharmed has entered into an exclusive agreement with Santen SAS, enabling Eupharmed to continue to distribute Cationorm® in Italy.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC